Relationship between chlorhexidine gluconate concentration and microbial colonization of patients' skin.


Journal

Infection control and hospital epidemiology
ISSN: 1559-6834
Titre abrégé: Infect Control Hosp Epidemiol
Pays: United States
ID NLM: 8804099

Informations de publication

Date de publication:
28 May 2024
Historique:
medline: 28 5 2024
pubmed: 28 5 2024
entrez: 28 5 2024
Statut: aheadofprint

Résumé

To characterize the relationship between chlorhexidine gluconate (CHG) skin concentration and skin microbial colonization. Serial cross-sectional study. Adult patients in medical intensive care units (ICUs) from 7 hospitals; from 1 hospital, additional patients colonized with carbapenemase-producing Enterobacterales (CPE) from both ICU and non-ICU settings. All hospitals performed routine CHG bathing in the ICU. Skin swab samples were collected from adjacent areas of the neck, axilla, and inguinal region for microbial culture and CHG skin concentration measurement using a semiquantitative colorimetric assay. We used linear mixed effects multilevel models to analyze the relationship between CHG concentration and microbial detection. We explored threshold effects using additional models. We collected samples from 736 of 759 (97%) eligible ICU patients and 68 patients colonized with CPE. On skin, gram-positive bacteria were cultured most frequently (93% of patients), followed by On a cross-sectional basis, higher CHG skin concentrations were associated with less detection of gram-positive bacteria and

Identifiants

pubmed: 38804007
pii: S0899823X24000813
doi: 10.1017/ice.2024.81
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-6

Auteurs

Yoona Rhee (Y)

Division of Infectious Diseases, Rush University Medical Center, Chicago, IL, USA.

Andrew T Simms (AT)

Division of Infectious Diseases, Rush University Medical Center, Chicago, IL, USA.

Michael Schoeny (M)

Department of Community, Systems and Mental Health Nursing, College of Nursing, Rush University Medical Center, Chicago, IL, USA.

Arthur W Baker (AW)

Division of Infectious Diseases, Duke University School of Medicine, Durham, NC, USA.

Meghan A Baker (MA)

Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA, USA.
Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA, USA.

Shruti Gohil (S)

Division of Infectious Diseases, University of California, Irvine School of Medicine, Irvine, CA, USA.

Chanu Rhee (C)

Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA, USA.
Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA, USA.

Naasha J Talati (NJ)

Division of Infectious Diseases, Penn Presbyterian Medical Center, University of Pennsylvania, Philadelphia, PA, USA.

David K Warren (DK)

Division of Infectious Diseases, Washington University School of Medicine, St Louis, MO, USA.

Sharon Welbel (S)

Division of Infectious Diseases, Cook County Health, Chicago, IL, USA.

Karen Lolans (K)

Division of Infectious Diseases, Rush University Medical Center, Chicago, IL, USA.

Pamela B Bell (PB)

Division of Infectious Diseases, Rush University Medical Center, Chicago, IL, USA.

Christine Fukuda (C)

Division of Infectious Diseases, Rush University Medical Center, Chicago, IL, USA.

Mary K Hayden (MK)

Division of Infectious Diseases, Rush University Medical Center, Chicago, IL, USA.

Michael Y Lin (MY)

Division of Infectious Diseases, Rush University Medical Center, Chicago, IL, USA.

Classifications MeSH